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Abstract 
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGID), which is 
biopsychosocial in nature, with a gut-brain interaction.  IBS has no biological marker and 
is often diagnosed through exclusion of other diagnostic possibilities, making it 
challenging to treat and often frustrating for individuals who suffer from it.  Most IBS 
patients will first present at their family medicine physicians’ offices, as it is the most 
common FGID.  The purpose of this study was to determine whether there is a difference 
in knowledge about IBS and whether there were negative attitudes toward IBS among 
family medicine physicians and among patients diagnosed with IBS.  Family medicine 
physicians, including family medicine residents, and IBS patients, completed surveys to 
study their attitudes toward and knowledge about IBS, including demographic 
questionnaires, an attitudes measure, and a 14-item knowledge questionnaire.  This study 
found that IBS patients and family medicine physicians both lack knowledge about IBS.  
This study also found that family medicine physicians perceive more of a lack of control 
over IBS, perceive more negative emotions related to IBS, and perceive IBS to be more 
chronic, compared to IBS patients.  Further, IBS patients perceive their IBS to be more 
puzzling and mysterious to them compared to family medicine physicians.  Due to these 
results, more education and training is needed about IBS for family medicine physicians, 
who can then educate their patients appropriately about the condition.  
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 Chapter 1: Introduction 
Statement of the Problem 
Irritable bowel syndrome (IBS) is a recurring and chronic functional bowel 
disorder consisting of abdominal pain, cramping, bloating, gas, diarrhea, and constipation 
(Hungin et al., 2014).  It affects the small and large intestines, causing these symptoms in 
the gut or bowel.  It is a “syndrome” because it is a group of various symptoms that 
aggravate the gut; however, these symptoms may be expressed differently depending on 
the individual (Gucht, 2015).  IBS is also considered a “gut-brain interaction” or disorder, 
because the brain influences the gut, for instance, through stress and anxiety (Drossman, 
2016).  Also, IBS is usually diagnosed by using symptom-based criteria because there are 
no specific biological markers for the diagnosis (Hungin et al., 2014).   
IBS affects approximately 11% of adults worldwide (Ooi, Correa, & Pak, 2019) 
and 10% to 15% of adults in the United States (Hungin et al., 2014).  It accounts for 
about 50% of referrals to gastroenterologists and is the most common functional bowel 
disorder worldwide (Pilgrim & Schub, 2016).  It is the seventh most common diagnosis 
made by all physicians in the United States, accounting for about 12% to 14% of primary 
care visits (Inadomi, Fennerty, & Bjorkman, 2003).  Therefore, IBS may be more 
common among patient visits to primary care settings compared to primary care visits for 
diabetes, hypertension, or asthma (Lacy et al., 2006), meaning most individuals suffering 
from IBS will first go to their primary care or family medicine physicians instead of other 
types of doctors (Hungin et al., 2014).  
IBS also has a large economic impact, costing directly $1.6 billion and indirectly 
$19.2 billion yearly (Ladabaum et al., 2012).  In one study, individuals with IBS missed 
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more work, spent more time in bed, and missed more daily activities compared to 
individuals without IBS.  About one fourth of people with IBS in the study worked fewer 
hours, 67% believed they were less productive at work due to symptoms, and individuals 
with IBS were twice as likely to miss work compared to people without IBS (Hungin, 
Chang, Locke, Dennis, & Barghout, 2005).  IBS has an economic effect in which yearly 
costs to manage and treat it are estimated to be $15 billion to $30 billion due to missed 
work or school, recurrent doctor visits, comorbid conditions, use of medication, and 
avoidable surgery (Lacy et al., 2006). 
The patient and health care provider relationship plays a vital role in patients’ 
experiences of the illness (Halpert & Godena, 2011).  Moreover, many IBS patients 
reportedly believe their physicians do not sufficiently educate them about IBS and its 
associated symptomatology or provide enough support.  Many IBS patients also believe 
physicians do not attempt to fully understand patients’ experiences living with IBS (Lacy 
et al., 2007).  Individuals with IBS often have a significant decrease in quality of life 
(Heitkemper, Carter, Ameen, Olden, & Cheng, 2002; Lacy et al., 2006).  Conversely, 
many primary care and family medicine physicians are knowledgeable about 
comorbidities, such as depression, anxiety, and stress (Hungin et al., 2014), and that an 
estimated 50% of individuals with IBS experience a diagnosis of a psychological disorder 
in addition to IBS, often depression and/or anxiety (Dainty, Allcock, & Cooper, 2014). 
Due to the common comorbidities with IBS, two evidenced-based psychological 
treatments include cognitive behavioral therapy (CBT; Craske et al., 2011; Laird, Tanner-
Smith, Russell, Hollon, & Walker, 2016; Sugaya, Nomura, & Shimada, 2012; van 
Tilburg, Palsson, & Whitehead, 2013) and mindfulness based therapy (Zomorodi, Abdi, 
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& Tabatabaee, 2014).  Pharmacological treatments are also common, including 
loperamide, fiber supplements, tricyclic antidepressants, selective serotonin reuptake 
inhibitors (SSRIs), antispasmodics, rifaximin, pregabalin, and probiotics, which are often 
guided by the specific symptoms (Trinkley & Nahata, 2011).   
Literature Review 
Medical training.  Medical education in the United States can be from an 
osteopathic (doctor of osteopathic medicine [DO]) or allopathic (doctor of medicine 
[MD]) program (American Medical Association, 2016; American Osteopathic 
Association, 2017).  There are many similarities between allopathic and osteopathic 
training, including utilization of the same Medical College Admission Test (MCAT), 
length of program (four years), matriculation after completing an undergraduate degree, 
certification to take and pass board exams, opportunity to study and practice any 
specialty, and three to seven years of residency after medical school.  There are also 
various differences between allopathic and osteopathic schools.  Allopathic applicants 
use the American Medical College Application Service (AMCAS) to apply and take the 
United States Medical Licensing Exam (USMLE); there are 141 allopathic schools in the 
United States and 17 in Canada.  Osteopathic applicants use the American Association of 
Colleges of Osteopathic Medicine (AACOM) when applying, take the Comprehensive 
Osteopathic Medical Licensing Examination (COMLEX) and may choose to take the 
USMLE, and receive further training and education about the musculoskeletal system and 
osteopathic manipulative treatment (OMT); there are 35 osteopathic medical schools in 
the United States (AACOM, 2019).  
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According to the American Academy of Family Physicians (AAFP; 2017), a 
family medicine doctor is defined as a physician who has specific attitudes, skills, and 
knowledge through his or her education and residency training to “provide continuing 
and comprehensive medical care, health maintenance and preventative services to each 
member of the family regardless of sex, age, or type of problem, be it biological, 
behavioral, or social” (Family Physician, Definition section, para. 1).  On the other hand, 
the AAFP has stated that primary care involves the primary care physician, other 
physicians who practice some primary care in their work, and providers who are not 
physicians.  One definition of primary care states that it is provided by a physician who is 
trained to meet a patient at first contact (e.g., a patient who is undiagnosed or has 
symptoms of an unknown origin) and provide a continuation of services for any 
symptoms or health reasons (e.g., for chronic, acute, or preventative reasons).  The AAFP 
has stated, “primary care includes health promotion, disease prevention, health 
maintenance, counseling, patient education, diagnosis and treatment of acute and chronic 
illnesses in a variety of health care settings” (Definition #1 – Primary Care section, para. 
2).   Examples of various health care settings include any office, inpatient or critical care 
facility, long-term facility, day care, and home care.  Further, a primary care physician 
often serves as a personalized provider while working with other health care 
professionals, whether for referrals or consultation. (AAFP, 2017).  According to the 
AAFP, a primary care physician specializes in family medicine, internal medicine, or 
pediatrics.   
An important distinction the AAFP (2017) has made involves the difference 
between primary care and family medicine.  Even though the AAFP has noted that 
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primary care and family medicine physicians both provide primary care services, AAFP 
has explained that these two terms do not hold the same meaning.  Indeed, primary care 
does not include all of the roles of a family medicine physician (AAFP, 2017).  For 
instance, a family physician is one who is qualified through his or her residency training 
and education to provide care to all patients from a family despite age, sex, or presenting 
problems (AAFP, 2017).  Therefore, for the purpose of this study, the focus was 
specifically on family medicine physicians and not overall primary care.     
When training to become a family medicine physician, one must graduate from a 
four-year allopathic (MD) or osteopathic (DO) medical school.  After medical school, a 
family medicine physician must complete three years of residency, during which he or 
she receives training in labor and delivery, emergency medicine, surgery/procedures, 
pediatrics, hospital care, and geriatrics, in order to gain the skills to provide care to all 
patients across the life span.  The first year of residency is often called internship year, 
and is when the resident must take the final part of the USMLE or COMLEX exam and 
rotate among various medical specialties and disciplines.  The second and third years of a 
family medicine residency are spent practicing in a specific specialty or specialties, with 
much of the time spent in a family medicine setting.  After residency, a family medicine 
physician can complete a one-year fellowship training program or become an attending 
family medicine physician, meaning he or she practices without the supervision of an 
attending physician (AAFP, 2017).  
Functional gastrointestinal disorders.  A common grouping of diagnoses 
encountered by residents and attending physicians is functional gastrointestinal disorders 
(FGIDs).  FGIDs are considered the most common gastroenterology diagnoses.  FGIDs 
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are considered biopsychosocial disorders, with a gut and brain interaction (Chang et al., 
2006; Drossman, 2016), and include muscular contractions or spasms, “visceral 
hypersensitivity, altered mucosal and immune function, altered gut microbiota, and 
altered central nervous system processing” (Drossman, 2016, p. 1268).  FGIDs are not 
explained by an identifiable abnormal structure within the body.  Instead, FGIDs are 
considered bidirectional in nature, in which an individual’s mental health affects his or 
her symptom expression of the FGID and vice versa (Dear et al., 2018).  Only within the 
past few decades have FGIDs started to be considered from a biopsychosocial rather than 
dualistic perspective, the former of which involves integrating mental and physical health 
to conceptualize a person as a whole entity.  By utilizing the biopsychosocial model with 
FGIDs, such as including neurogastroenterology and the brain-gut relationship, 
opportunities for new medication and treatments were established.  It is understood that 
genetic, sociocultural, and environmental factors can influence an individual’s 
development regarding personality, vulnerability to stress, and psychological health, 
including coping skills and ability to handle stressors.  Nevertheless, it has been found 
that these various aspects of an individual also affect his or her risk for 
gastroenterological dysfunctions, showing that the brain and gut interaction also affects 
central nervous system (CNS) functioning, and can result in a FGID (Drossman, 2016; 
Drossman & Hasler, 2016). 
There are eight categories of FGIDs: (a) esophageal disorders, (b) gastroduodenal 
disorders, (c) bowel disorders (e.g., IBS), (d) centrally mediated disorders of 
gastrointestinal (GI) pain, (e) gallbladder and sphincter of oddi (SO) disorders, (f) 
anorectal disorders, (g) childhood functional GI disorders: neonate/toddler subtype, and 
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(h) childhood functional GI disorders: child/adolescent subtype.  Bowel disorders include 
IBS and functional constipation, functional diarrhea, functional abdominal 
bloating/distension, unspecified functional bowel disorder, and opioid-induced 
constipation (Drossman, 2016; Drossman & Hasler, 2016).  In order to effectively treat 
an individual diagnosed with a FGID, a strong relationship between physician and patient 
is vital.  A strong patient-physician relationship can increase the satisfaction of the 
patient, thereby increasing treatment adherence, decreasing symptoms, and improving 
health overall (Drossman, 2016).  
Irritable bowel syndrome.  IBS consists of abdominal pain, cramping, bloating, 
gas, diarrhea, and constipation (Drossman, 2016).  It is a recurring and chronic condition 
affecting the small and large intestines, causing various symptoms in the gut or bowel 
(Drossman, 2016).  More recent research has found that when an individual experiences 
IBS, the gut microbiome and changes in the diversity of the microbiota, or 
microorganisms in the gut, affects the individual’s immune system, and causes gut 
inflammation that, in turn, affects the interaction between the gut and the brain (Ooi et 
al., 2019).  IBS is referred to as a brain-gut disorder because the brain influences the 
symptoms in the gut, through stress and anxiety (Drossman, 2016).  It is called a 
syndrome because it is a set of various symptoms; however, the symptoms may be 
expressed differently depending on the individual (Gucht, 2015).  As such, there 
numerous subtypes of IBS have been used to classify differences in symptom 
presentation: IBS-constipation (IBS-C), IBS-diarrhea (IBS-D), IBS-mixed type (IBS-M), 
and IBS-unclassified (IBS-U).  IBS-M is classified as alternating between diarrhea and 
constipation.  IBS-U does not fit into exact criteria to meet symptoms of the other types 
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of IBS (Singh et al., 2015).  One study conducted by Singh et al. (2015) compared 
indicators of quality of life—including food avoidance, relationships and social 
interactions, and daily activities—among patients with the four subtypes of IBS.  Singh et 
al. found patients with IBS-D and IBS-M had a significantly lower quality of life 
compared to patients with IBS-C.  IBS-D patients avoided more foods and were impacted 
more in their daily lives compared to IBS-C.  Due to the negative impact on daily living, 
activities, and relationships, patients with IBS-M were found to have decreases in their 
social activities compared to patients with IBS-C.  Overall, this study found IBS-D and 
IBS-M to be similar in quality of life effects.  Moreover, patients with IBS-D or IBS-C 
may eventually meet criteria for the IBS-M subtype.  Another contributor to decreased 
quality of life is that individuals with IBS often see various doctors and undergo many 
diagnostic tests before being officially diagnosed with IBS.  Genetics and heredity, 
mucosal inflammation, and the interpretation of the sensory signals all play a role, 
depending on the individual (Talley & Spiller, 2002).  Overall, individuals with IBS 
experience unpredictability with regards to pain and discomfort with various gut and 
bowel symptoms.  In turn, this contributes to feelings of emotional difficulties and 
isolation, worry, stress, and a decrease in feeling in control (Chang et al., 2006).  
IBS and culture.  A person’s culture can also affect how he or she experiences 
IBS and how he or she views IBS and its symptoms.  Most studies about IBS focus more 
on Western, Caucasian individuals; however, there have been studies examining IBS in 
other cultures.  For example, in one study comparing Hispanic and non-Hispanic 
Caucasians in the state of Texas, Hispanic individuals were seen to self-medicate more 
often than non-Hispanic Caucasians.  For example, the Hispanic individuals in this study 
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utilized more culture-specific folk remedies and herbal teas for symptoms.  The Hispanic 
individuals also indicated to have a more negative view of their conditions and reported 
worrying more about their health and conditions.  This study found that Hispanics were 
less likely to seek out  health care professionals for their IBS symptoms.  Therefore, 
ethnicity may affect views of individuals’ general health, which may, in turn, affect their 
health behaviors and adherence (Zuckerman, Guerra, Drossman, Foland, & Gregory, 
1996).  
Among Japanese individuals, the view of IBS is changing due to the country 
becoming more modernized.  Traditionally, Japanese individuals believed in a strong 
mind and body connection.  Modern views are replacing this belief though with a 
dichotomous view of IBS.  Japanese physicians are viewing IBS as either psychogenic or 
organic, meaning the biopsychosocial model is not being utilized.  Further, if IBS patients 
in Japan are viewed as having the syndrome due to solely psychological reasons, it is 
common for these patients to not adhere to psychological treatment because of the 
stigmatization of mental health concerns in Japan.  Like in many countries, seeing a 
psychologist or psychotherapist is viewed as necessary only for severe psychological 
cases.  Japan is said to be similar to the United States in regard to the conflict between the 
biopsychosocial view of IBS and the medical model view of IBS.  Nevertheless, 
biopsychosocial practices are becoming more known and accepted both in Japan and in 
the United States (C. D. Gerson & M. Gerson, 2010).   
   In India, IBS is viewed differently depending on gender.  Despite studies stating 
that the majority of IBS patients are female, in India, the majority of diagnosed IBS 
patients are male.  This is due to Indian studies in the 1980s and 1990s focusing on male 
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IBS patients; however, this may be due to females, during this time in India, not seeking 
out health care, specifically in rural areas where females in India were in submissive roles 
and not allowed to seek out health care from professionals, nor allowed to participate in 
studies regarding IBS or other medical concerns.  These results may change due to India 
changing and becoming more modern in its views and treatment of women.  Another 
cultural aspect in India regarding IBS is that IBS is caused by an infection in the small 
intestine and that an individual with IBS needs to dispel flatulence to relieve symptoms.  
Additionally, even though IBS is often associated with depression and anxiety, seeking 
psychological treatment is still stigmatized in the Indian culture (C. D. Gerson & M. 
Gerson, 2010).   
 In Mexican culture, expressing one’s emotions is viewed as normal.  Therefore, 
IBS is viewed as being partially caused by stress in one’s life, specifically familial stress.  
As a result, familial influences and familial relationships affect one’s health significantly 
in the Mexican culture.  In Mexico, one part of the treatment for IBS includes processing 
family relationships.  Moreover, due to the significant cultural influence of “machismo,” 
the belief that men should take pride in their masculinity, Mexican women are more 
likely to be open about and discuss their GI symptoms, whereas Mexican men are more 
likely to feel embarrassed and utilize humor regarding their IBS symptoms (C. D. Gerson 
& M. Gerson, 2010). 
 Similar to Mexican culture, in Italy, views about IBS are relationship-focused.  
There, IBS is viewed as being influenced by emotional distress and familial and relational 
stress.  Due to the strong value of family in Italy, communication difficulties and family 
issues are considered significant influences on Italian IBS patients and having such 
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problems is viewed as a reduction in one’s strength, as one’s family is viewed as “a part 
of the self” (C. D. Gerson & M. Gerson, 2010, p. 711).  In one study in southern Italy, 
30% of IBS patients stated that their IBS symptoms are because physicians did not 
understand their health difficulties (C. D. Gerson & M. Gerson, 2010).        
 In Hong Kong, one’s health is viewed as related to the environment.  Therefore, if 
a person is ill, then that person is not in balance with his or her environment.  This is 
illustrated by the concept of yin and yang in Chinese culture, which postulates that 
finding balance in one’s life is necessary for health.  Hence, IBS patients in Hong Kong 
may feel a personal responsibility for their symptoms and may attempt to restore balance 
to their lives.  This may be implemented by eating cold and hot foods and also by 
meeting with Chinese traditional healers who would offer more Chinese belief-congruent 
treatments (C. D. Gerson & M. Gerson, 2010).   
 In Romania, due to the political history of being under communist rule for some 
time, there was no research conducted about IBS until the 1990s.  Even though there are 
stress-related concerns seen with Romanian IBS patients, psychological treatments are 
still not fully accepted or used.  Nevertheless, Romanian individuals are starting to meet 
with psychologists more, though these psychologists may continue to be influenced by 
the political suppression lingering from many years of communist rule (C. D. Gerson & 
M. Gerson, 2010).   
IBS and gender.  In the United States, FGIDs (including IBS) are diagnosed 
more in women than men (Chang et al., 2006; Payne, 2004).  Further, living with IBS 
creates different experiences between men and women due to cultural and social gender 
normative expectations (Björkman, Dellenborg, Ringström, Simrén, & Jakobsson Ung, 
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2014; Smith, 2015).  These different experiences mean men and women may express IBS 
differently, with different prevalent symptoms (Payne, 2004; Smith, 2015), different 
effects on daily life, and different perceptions of IBS (Payne, 2004).  Therefore, living by 
the gender stereotypes and norms common in the culture creates different experiences of 
IBS for masculine or feminine individuals (Chang et al., 2006; Smith, 2015).  
Nevertheless, even though more women than men are diagnosed with IBS and symptom 
presentations and patterns may differ by gender, the symptoms and experiences of IBS 
seem to be overall similar between the two genders (Talley & Spiller, 2002) 
One study by Toner and Akman (2000) stated that, generally, FGIDs might be 
found in more women than men because of a relationship with the female gender role 
instead of with the female sex.  This study, which did not directly study men with IBS, 
examined women with IBS and the impact of the female gender role.  Toner and Akman 
found that among women with IBS attending a CBT program, their major concerns were 
based on socially proper female behavioral norms, such as loss of control over bodily 
functions, a common symptom of IBS.  Also, women reported more anxiety surrounding 
symptoms of IBS and the effects of these symptoms on their appearance, such as feeling 
bloated compared to feeling thin.  Women reported feelings of shame surrounding bowel 
symptoms, possibly because of a culture in which girls are taught they should be clean, 
neat, and in control of these functions and boys being taught that they can be open, 
“dirty,” and utilize bowel functions as a type of enjoyment.  This can create more silence 
and embarrassment for women living with IBS (Toner & Akman, 2000).  Conversely, as 
individuals with IBS are more likely to seek health care once symptoms affect their daily 
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lives, women’s increased likelihood of seeking treatment and, therefore, being diagnosed 
may relate to these feelings of embarrassment and shame (Toner & Akman, 2000).   
Björkman et al. (2014) found that health care professionals will, at times, 
stereotype patients with IBS based on gender.  Male patients described feeling 
uncomfortable due to IBS being viewed as a female illness and, therefore, having their 
symptoms viewed as purely psychosomatic and as “emotional and weak” (Björkman et 
al., 2014, p. 1339).  Further, female patients described wanting to be viewed as “good 
patients” (Björkman et al., 2014, p. 1339), which may relate to discomfort in reporting 
their symptoms to these professionals.  Female patients also reported being told by health 
care professionals that the symptoms were purely psychological and the more symptoms 
they reported, the more often they were labeled as “whiny and neurotic” and it “being in 
their heads” (Björkman et al., 2014, p. 1339).  This, in turn, caused some of these women 
to blame themselves for their IBS symptoms (Björkman et al., 2014).  Again, gender 
creates different experiences for men and women (Björkman et al., 2014; Smith, 2015), 
even with health care professionals (Björkman et al., 2014). 
IBS and mental health.  Difficult life events and stress in general are recognized 
to negatively impact many physical illnesses and mental disorders.  Specifically, amount 
of daily stress can worsen or improve IBS symptoms.  In one study, individuals with IBS 
reported more life stress and experiencing more stressful events compared to a healthy 
control group.  Also, the interaction between IBS and stress can be bidirectional; stressful 
life events can exacerbate IBS symptoms or IBS symptomatology can cause more stress.  
This portrays that life stress can significantly impact IBS and the symptomatology of it 
(van Tilburg et al., 2013).  Due to the stress that is related to experiencing IBS symptoms, 
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the stress that can exacerbate symptoms, and other environmental and genetic factors, 
IBS is often comorbid with anxiety, depression, and/or other gastrointestinal disorders 
(Hungin et al., 2014; Lee et al., 2015; Sugaya et al., 2012; van Tilburg et al., 2013).  If an 
individual has anxiety in addition to IBS, then the anxiety can be exacerbated from 
experiencing IBS symptoms or the IBS symptoms can worsen his or her anxiety.  
One study conducted by Lee et al. (2015) found that psychological diagnoses, 
such as depression, anxiety disorders, sleep disorders, and bipolar disorder, were more 
diagnosed with individuals with IBS compared to a control group.  The highest risk for 
being diagnosed with these psychological disorders is within one year of being diagnosed 
with IBS, and this high risk continues for more than five years after being diagnosed.  In 
the same study, schizophrenia was not significantly found in individuals with IBS (Lee et 
al., 2015).  Related to depression, anxiety, and sleep disorders often being comorbid with 
IBS, van Tilburg, Palsson, and Whitehead (2013) found that the factors that relate to a 
person’s psychological well-being are often associated with the severity of IBS 
symptoms, including stress, personality and temperament, coping style, psychological 
distress, and somatization.  Stress can directly affect IBS symptoms and the expression of 
these symptoms.  Participants in this study stated that they experienced more lifetime 
stressful events compared to the healthy control group.  This study found a correlation 
between life stressors, such as sexual abuse and marital separation, and IBS.  Further, IBS 
sufferers portray more stress reactivity compared to the control group; thus, stress has a 
direct negative impact on the gut for an individual who has IBS (van Tilburg et al., 2013).   
An individual’s personality or temperament can also make him or her more 
vulnerable to stress.  For example, neuroticism is a common characteristic portrayed with 
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IBS.  Studies have found that people high in neuroticism have a higher degree of 
reactance to stress (van Tilburg et al., 2013).  This also relates to people’s coping styles 
and how they manage stress.  The manner people cope with stress and pain affects the 
outcome of their health and expression of IBS symptoms.  A major predictor of pain 
intensity is pain catastrophizing.  Catastrophizing pain is amplifying the threat of the 
pain, thus causing the individual to feel helpless.  This catastrophizing is related to 
greater pain and disability for people with IBS.  Life stressors and one’s pain 
catastrophizing can also cause more psychological distress, such as anxiety and 
depression (van Tilburg et al., 2013).  Anxiety and depression are related to more 
gastrointestinal problems and decreases in quality of life for people with IBS (Lacy et al., 
2006; van Tilburg et al., 2013).  In about 30% to 90% of IBS sufferers, psychological 
symptoms, such as depression and anxiety, can be very severe and a diagnosis of a 
comorbid psychological disorder is probable (van Tilburg et al., 2013).   
Anxiety disorders generally and panic disorder specifically are common among 
IBS sufferers.  One study showed a higher level of anxiety sensitivity with IBS sufferers, 
which increases with the expression of IBS symptoms.  Conversely, an individual’s 
experience of GI symptomatology can increase his or her physical fears, which is a part 
of anxiety sensitivity (Sugaya et al., 2012).  This anxiety sensitivity is also associated 
with pain catastrophizing and avoidant behavior, thus showing that anxiety can be linked 
with negative symptom-related cognitions for IBS sufferers.  Anxiety sensitivity can be 
trait-like and lasting if fused with these symptom-related cognitions.  The individual 
starts to believe that anxiety and anxiety-provoking symptoms are harmful to the body, 
which can exacerbate and provoke more anxiety and more IBS symptomatology.  Also, 
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an individual experiencing more anxiety associated with IBS symptomatology has a 
higher probability of also developing avoidant behaviors with different activities, in order 
to try and avoid both IBS symptoms and anxious feelings.  This can create a negative 
cycle of increased anxiety, isolation, and IBS symptoms.  Nevertheless, it is difficult to -
know the direct cause and effect with psychological and IBS symptoms because it is 
bidirectional, meaning psychological distress can precede IBS or IBS can precede 
psychological distress, due to the brain-gut connection (van Tilburg et al., 2013).   
Somatization is also a common psychological concern associated with IBS, 
specifically when one catastrophizes pain and reports more life stressors.  Somatization 
refers to the tendency to report numerous physical symptoms.  Individuals who have an 
increased incidence of somatization tend to be hypervigilant and more likely to notice 
somatic symptoms, and then relate these symptoms directly to an illness, such as IBS.  
Many IBS patients eventually have another FGID with IBS or other symptomatology, 
such as chronic pain syndromes, chronic fatigue, frequent urination, bad breath, and heart 
palpitations (van Tilburg et al., 2013).   
These common psychological factors seen with IBS patients are interconnected 
and function together.  Life stressors, perceptions of these stressors, and the way an 
individual copes with these stressors are affected by his or her temperament and can 
relate to somatization, which can cause more anxiety and depression.  This psychological 
distress is also directly related to coping style, personality, and the life stressors the 
individual is experiencing (van Tilburg et al., 2013).  An individual’s attitudes about his 
or her IBS condition also affects his or her psychological well-being and self-confidence.  
One study showed that one fourth of IBS patients stated their self-confidence decreased 
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because of IBS and its symptoms.  Also, more than half of individuals with diagnosed 
IBS in the study told their partners, family members, and friends about their disorders, 
but only 22% told their colleagues and 16% told their employers, depicting possible 
feelings of embarrassment or fear related to others knowing about their conditions 
(Hungin et al., 2005).   
Diagnosis of IBS.  Physicians diagnose IBS using the Rome Criteria (Bai et al., 
2016; Drossman, 2016), Manning Criteria (Bai et al., 2016; Manning, Thompson, 
Heaton, & Morris, 1978), or exclusion of other diagnoses due to no biological markers of 
IBS, meaning a physician uses a patient’s set of symptoms to diagnose (Hungin et al., 
2014).  Despite these assessment options, according to Bai et al. (2016), the majority of 
physicians do not utilize the Rome or Manning Criteria to diagnose IBS.   
The Manning Criteria assessment is a questionnaire inquiring about 15 specific 
gut functioning symptoms, such as whether the respondent has experienced looser stools 
at onset of pain, more frequent bowel movements at onset of pain, or urgency of 
defecation.  Manning and colleagues developed this questionnaire by screening 15 
common IBS symptoms among 109 patients (Manning et al., 1978).  Manning et al. were 
the first to create criteria for IBS by first comparing individuals experiencing abdominal 
pain that did or did not meet full criteria for an IBS diagnosis.  Since then, the Rome 
Criteria were established with more details and specifications (Spiller et al., 2007).       
The Rome I Criteria were established in 1990.  Following the realization that 
there needed to be more accuracy in the symptom criteria, the Rome II Criteria were 
published in 1999, and the Rome III Criteria were published in 2006.  The Rome III 
Criteria became even more specific by stating a timeline of how long pain must be 
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experienced, and that the IBS symptoms must be experienced within the past three 
months to be considered a current IBS diagnosis (Spiller et al., 2007).  The Rome 
Foundation is now well known as an influential foundation that develops diagnostic 
benchmarks from research, while delivering education about all FGIDs around the world.  
When developing the Rome IV Criteria in 2016, the Rome Foundation attempted to 
attend to various weaknesses, including the name “functional gastrointestinal disorders” 
sounding stigmatizing and not exactly fitting the diagnoses.  Previous versions of the 
Rome Criteria were not considered useful in actual practice, as they did not specify the 
steps to take before using the Rome Criteria, they oversimplified the experiences of 
patients, and they used a Western medicine approach that made it more difficult to apply 
to other cultures.  Therefore, in order to make the Rome Criteria more user-friendly in 
clinical practice, the Rome IV Criteria were developed to be more symptom-based 
(Drossman, 2016).  
Treatment of IBS.  There are few diagnostic tools to assess for IBS; however, 
there are many types of treatment methods used for the syndrome.  One article written by 
a nurse practitioner, Harmon (2007), outlined IBS and its treatment options and discussed 
the importance of helping the IBS patient realize that improvement and decrease in IBS 
symptoms may be a slow and ongoing process.  The article first outlines 
nonpharmacological treatments, such as lifestyle and dietary changes.  IBS patients must 
identify their individualized food triggers, such as lactose, aspartame, caffeine, alcohol, 
beans, cabbage, and fatty and spicy foods (Harmon, 2007); however, negative reactions 
to lactose may be based on genetics, due to this intolerance being mainly seen in 
northwestern Europeans with IBS (Spiller et al., 2007).  IBS is also associated with 
IBS ATTITUDES AND KNOWLEDGE   19
difficult to digest foods in general, eating short-chain/hard to digest carbohydrates 
(fructans in wheat and bran), and insoluble fiber, but the ingestion of healthy, soluble 
fiber depends on the type of IBS being experienced (El-Salhy & Gundersen, 2015).   
Harmon (2007) suggested keeping a food diary for one to two weeks in order to 
identify these possible food triggers, as well as keeping record of when the IBS patient 
feels stressed and types of bowel movements.  Further, before utilizing more complicated 
treatments regarding food elimination, it is suggested to first change the amount of 
carbohydrates, fiber, and fat by eliminating each and then slowly reintroducing these 
types of foods into the individual’s diet one by one, in order to figure out which food 
intolerances may exist (Spiller et al., 2007).  Harmon also suggested identifying times of 
stress for an IBS patient and the use of relaxation tools, such as meditation, yoga, 
exercise, relaxation tapes, aromatherapy, hypnotherapy, and psychotherapy.  Moreover, 
combining a healthy diet with exercise and probiotics are said to decrease IBS symptoms 
even more (El-Salhy & Gundersen, 2015).     
Other specific treatments for IBS that are becoming more widely used are a low 
fermentable oligo-, di- and monosaccharides, and polyols (FODMAP) diet, prebiotics, 
and probiotics (Ooi et al., 2019).  These treatments have the ability to alter the 
inflammation in the gut often found with IBS, which is caused by altered gut 
microbiome.  Probiotics are healthy living bacteria that can have various health benefits 
when taken.  Unlike probiotics, prebiotics are “non-viable dietary substances” that, 
instead, are nutrients for the microbiota or microorganisms in the gut (Ooi et al., 2019).  
FODMAPs are fermented, short-chain carbohydrates that, for more gut sensitive 
individuals, become fermented in the colon because of the small intestine not being able 
IBS ATTITUDES AND KNOWLEDGE   20
to complete absorption of these foods.  In other words, when foods containing 
FODMAPs are fermented in one’s colon, it can potentially cause gas, pain, bloating, 
diarrhea and/or constipation, and other gut sensitivities, such as symptoms of IBS.  This 
occurs when the individual is intolerant or sensitive to a FODMAP food or FODMAPs.  
Therefore, a low FODMAP diet consists of an individual first eliminating all FODMAPs 
from his or her diet, whether it be fructose, lactose, fructans, galactans, or polyols, which 
are found in specific foods and chewing gum.  This person then reintroduces one 
FODMAP at a time back into his or her diet to gauge to which FODMAP(s) he or she is 
sensitive.  Once that person starts to reexperience IBS symptoms, he or she would now 
know which FODMAP(s) his or her gut and digestive symptom is intolerant to, and 
therefore, which foods to avoid.  Some common foods high in FODMAPs are beans, 
lentils, wheat, dairy, high fructose corn syrup, artificial sweeteners, chewing gum, garlic, 
onion, and fruits high in fructose.  Recent research has found efficacy for the alleviation 
of IBS symptoms with a low FODMAP diet and probiotics, but a lack of efficacy for the 
effectiveness of prebiotics when treating IBS (Ooi et al., 2019). 
Along with diet changes, patients with IBS are often prescribed medication for 
their symptoms.  Pharmacological treatments are prescribed based on specific IBS 
symptoms.  For IBS-C, laxatives are used, such as lactulose (brand name Cephulac), 
magnesium citrate, and magnesium hydroxide, to name a few.  Unfortunately, common 
side effects from laxatives are abdominal pain, diarrhea, nausea, and distention.  For IBS-
D, loperamide (brand name Imodium) is usually the first medication prescribed.  For 
bloating and gas symptoms of IBS, an antispasmodic is used, which helps relax the 
muscles.  Typical side effects for antispasmodics include nausea, vomiting, altered taste, 
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dry mouth, blurred vision, dysphagia, palpitations, and urinary hesitancy and retention.  If 
there are psychological diagnoses, the first-line medication is typically a selective 
serotonin reuptake inhibitor (SSRI).  SSRIs are proposed to change an individual’s 
threshold of pain for IBS symptoms; however, it is not known how they treat depression 
or anxiety for an IBS patient specifically.  The second-line of pharmacological treatment 
includes tricyclic antidepressants, which have the potential for more negative side effects 
than SSRIs.  Other treatment options for IBS that are not studied enough to be considered 
empirically based are peppermint, caraway oil, and artichoke leaf (Spiller et al., 2007).    
A study conducted by Henrich, Gjelsvik, and Martin (2018) looked at IBS 
patients using the Implicit Attitudes Test (IAT) to gauge IBS patients’ implicit 
identification with regard to health, being ill, and IBS.  This study examined 83 IBS 
patients and 129 healthy controls.  The healthy participants reported less fatigue, less IBS 
specific symptoms, and less somatic symptoms in general.  Among the 83 participants 
with IBS, this study found that these patients displayed weaker identification with being 
healthy compared to healthy individuals without IBS.  Therefore, these patients had more 
identification with being ill compared to healthy individuals.  Because patients identify 
more with being ill and unhealthy, this can affect specific illness-related cognitions and, 
therefore, symptom severity.  As such, CBT can be effective in treating IBS patients and 
these specific implicit attitudes (Henrich, Gjelsvik, & Martin, 2018). 
In general, CBT is used to decrease catastrophizing, somatization, and stress, and 
to improve coping strategies.  CBT helps replace maladaptive thought processes, such as 
catastrophizing, with positive cognitions and behaviors, which can help decrease 
symptoms of IBS (van Tilburg et al., 2013).  CBT is also proven to reduce anxiety for 
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IBS patients by helping them redefine their IBS experiences and recognize the connection 
between thoughts, feelings, behaviors, environment, and IBS symptoms.  CBT may 
empower the IBS patient as well, which will help shift from feeling helpless and hopeless 
to resourceful and optimistic.  Also, by empowering people with IBS, this will help them 
develop more effective coping strategies to improve quality of life.  CBT helps IBS 
patients recognize symptom-related cognitions and the interaction between anxiety, 
stress, and the severity of IBS symptoms (Sugaya et al., 2012).   
Drossman et al. (2003) studied individuals with severe IBS participating in a 12-
week one-hour treatment of CBT from the same psychologist or 12-week “attention 
control sessions” (Drossman et al., 2003).  These attention control sessions included 
reviewing symptom journals in a group and reading from an educational text about IBS.  
The other participants in this study either received a tricyclic antidepressant for 12 weeks 
or a placebo for 12 weeks.  The antidepressant medication was raised from 50 mg to 150 
mg in three weeks, or by 50 mg per week, and the side effects were closely recorded and 
watched.  The results of this study show that between the CBT and education treatment, 
CBT helped improve symptoms for IBS patients significantly more compared to the 
educational treatment.  Further, the tricyclic antidepressant compared to the placebo also 
showed to be more beneficial for people with IBS, if they could endure the side effects of 
the medication.  This study described the CBT treatment as altering attention, personal 
appraisals, cognitive schemas about sex, and attributions of IBS symptoms in order to 
help the individual with IBS form more helpful coping techniques (Drossman et al., 
2003).   
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Another subtype of CBT is CBT for stress management, which includes education 
about symptoms of IBS and the relationship between IBS and stress, self-monitoring of 
IBS symptoms, progressive muscle relaxation, cognitive reconstruction to recognize 
negative or threatening interpretations of events, and in-vivo exposure through a fear 
hierarchy of stressful events.  Another treatment approach utilized is CBT with 
interoceptive exposure, which helps lessen maladaptive beliefs and hypervigilance about 
IBS symptomatology, fear of the symptoms, and unhelpful behaviors associated with IBS 
symptoms.  This consists of education about IBS symptoms and how symptoms can 
cause conditioned behavior to respond in a maladaptive manner, self-monitoring of IBS 
symptomatology, learning how to shift attention and gain control instead of ruminating 
on the symptoms, cognitive therapy to confront maladaptive thoughts regarding the threat 
of IBS symptoms, and interoceptive exposure to the feared sensations associated with the 
disorder.  An attention control treatment was also used in this study, which consisted of 
education about IBS and its symptoms and self-monitoring the symptoms (Craske et al., 
2011).  All three of these options were studied by Craske et al. (2011) and were found to 
be effective in decreasing IBS symptoms by about 50% for the treatment groups.   
More recently, research has been conducted utilizing an Internet-CBT (iCBT) 
course that was developed for various chronic health conditions.  Dear et al. (2018) used 
this course with individuals with FGIDs.  With the completion of this course, they saw a 
significant decrease in depression, anxiety, and FGID symptoms altogether, as well as a 
higher completion rate compared to typical psychotherapy completion rates with 
individuals with FGIDs.  People with FGIDs typically do not have high completion rates 
of psychological treatment due to stigma, cost, availability of trained professionals in the 
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gastroenterology field, and travel time to treatment (Dear et al., 2018).  Therefore, iCBT, 
a CBT treatment delivered through the Internet, was developed to lessen these various 
barriers for FGID patients.  Another study conducted by M. G. Hunt, Moshier, and 
Milonova (2009) developed an iCBT treatment specifically for IBS patients, which 
showed a significant decrease in IBS symptoms and improvement in quality of life.  M. 
G. Hunt et al. (2009) also showed that these patients maintained a significant decrease in 
IBS symptoms and overall improvement in quality of life at a three-month follow-up (M. 
G. Hunt, Moshier, & Milonova, 2009).   
Another component of CBT treatment for IBS includes systematic exposure.  This 
is similar to exposure for anxiety disorders.  Therefore, the individual with IBS is 
exposed to bodily sensations and situations associated with IBS and IBS symptoms.  
This, in turn, helps break the negative cycle of hypervigilance to bodily sensations, pain 
and pain catastrophizing, and unhelpful coping responses, such as avoidance, control 
behaviors, and over monitoring of symptoms that intensify and maintain IBS symptoms 
(Hesser, Hedman-Lagerlöf, Andersson, Lindfors, & Ljótsson, 2018).  A study by Hesser 
et al. (2018) looked at the effects of systematic exposure on IBS and associated GI 
anxiety symptoms.  This study found that systematic exposure through iCBT treatment 
caused a decrease in behavioral avoidance, thereby causing a decrease in IBS symptoms.  
Specifically, the systematic exposure treatment in this study aimed to help IBS patients 
accept and let go of the short-term efforts to control symptoms, in order to decrease IBS 
symptoms in the long-term.  This is due to a decrease in attention given to symptoms and 
decreases in emotional reactivity to symptoms of IBS, helping individuals with IBS gain 
a sense of mastery and a sense of control over IBS. 
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Another treatment for IBS is hypnosis.  Hypnosis for IBS is not as researched; 
however, some hypnosis cases have proven to help people with IBS.  Hypnosis may help 
decrease multiple IBS symptoms and reduce catastrophizing, anxiety, and stressful life 
events.  Hypnosis may help an individual learn to relax and accept the symptoms of IBS 
by not catastrophizing about the symptomatology, but learning to be calm and not fight 
against the related anxiety.  Learning to accept the anxiety and not catastrophize IBS 
symptoms can help reduce the severity of physical IBS symptoms.  This is due to 
catastrophizing being the number one predictor of symptom severity (van Tilburg et al., 
2013).   
IBS and support.  An important factor during treatment for IBS is social support.  
It has been found that it is not the quantity of social support, but the quality of social 
support that helps patients with IBS.  Individuals who believe to have less social support 
are also likely to experience more life stress.  Moreover, individuals whose social 
supports do not understand the difficulties and symptoms of IBS will be more likely to 
have more life stress and more anxiety surrounding IBS symptoms.  This can easily 
exacerbate IBS.  Therefore, communicating about IBS to social supports can help patients 
reduce life stress and accompanying anxiety (J. M. Lackner et al., 2010).   
 One helpful support person for an IBS patient may be his or her physician; 
however, the patient-physician relationship is often challenging and frustrating for both 
the patient and the physician (Bellini et al., 2005; Chang et al., 2006; Dixon-Woods & 
Critchley, 2000).  It is challenging for patients because patients usually report feeling 
disappointed and not helped by physicians, due to no biological findings in medical tests 
and feeling as though physicians often communicate a lack of validation and acceptance 
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regarding their diagnoses and symptoms (Chang et al., 2006; Dixon-Woods & Critchley, 
2000).  Physicians usually experience difficulty because they report sharing in the 
patients’ dissatisfaction in the unclear etiology of IBS and limited treatment options for 
their patients (Dixon-Woods & Critchley, 2000).  Physicians are also frustrated with 
often not feeling successful when treating IBS (Bellini et al., 2005).  In one study in Italy, 
these feelings of frustration related to unsuccessful treatment may explain why two thirds 
of the patients studied were referred for a consultation with a specialist, including many 
gynecological referrals for female patients, due to the difficulty of differentiating between 
IBS and pelvic pain among females (Bellini et al., 2005).  Despite the challenges, in order 
to have more success with IBS treatment, patients and physicians must share trusting 
relationships that consist of clear explanations of the etiology and nature of IBS, options 
for treatment, and effects on daily lives, and provide opportunities for patients to discuss 
questions and concerns during patient-physician encounters (Chang et al., 2006).   
One major difficulty within the patient-physician encounter is that a person with 
IBS experiences the diagnosis like many other chronic illnesses, meaning it is long-term, 
unpredictable, with limited treatment options, and, at times, with stigma attached to it, 
causing people living with FGIDs like IBS to isolate themselves (Chang et al., 2006).  
This perception of stigma often relates to an increase of depression and anxiety, and a 
reduction in self-esteem, self-efficacy, and quality of life.  IBS patients view physicians 
as holding stigmatized views of their illness as well; however, this perception of existing 
stigma seems to decrease as age increases for the IBS patient (Taft, Keefer, Artz, Bratten, 
& Jones, 2011).  Further, people with IBS and other chronic conditions experience 
unpredictable, painful, and uncomfortable symptoms that affect their mood and, 
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subsequently, feelings of lack of control over their lives (Chang et al., 2006).  
 Although an IBS patient’s quality of life and daily functioning are affected, one 
study showed that IBS patients are more likely to adhere to health care behaviors and 
seek out health care treatment if experiencing a comorbidity when quality of life was 
affected, compared to seeking a health care professional solely for physical symptoms 
(Williams et al., 2006).  When IBS patients were asked about knowledge of IBS and 
knowledge of treatments, most IBS patients in one study stated changes in diet, 
prescription medication, and over-the-counter medication help improve their IBS 
symptoms.  When these same IBS patients were asked about who they go to for support, 
the majority stated they had someone in their lives with whom they could talk.  Most of 
the patients specifically identified their support people as significant others or spouses, 
closely followed by primary care physicians, and then families and friends.  Only 1.5% of 
the IBS patients in this study identified psychologists or psychiatrists support people 
(Lacy et al., 2007).    
Individuals with IBS may also experience anxiety regarding not knowing the 
actual cause of the syndrome and treatment (Stenner, Dancey, & Watts, 2000).  In two 
surveys of people with IBS, participants endorsed worry, frustration, isolation, and 
consistently anticipating when they would experience the next IBS symptom.  The survey 
also showed these IBS patients seek health care treatment a great deal and that IBS 
affects their daily lives (Stenner et al., 2000).  In one qualitative study, Bertram et al. 
(2001) found three main concerns among people with IBS.  The first concern highlighted 
included feelings of frustration regarding loss of control and predictability; effects on 
their daily lives; and limited empathy from family members, physicians, and coworkers, 
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which caused feelings of anger and frustration.  Another reason for their feelings of 
frustration included the lack of a sufficient medical explanation for IBS and not feeling 
believed or validated by their physicians.  In turn, these feelings of frustration were 
viewed to cause IBS patients more severe symptoms, which increased anger and 
frustration, sending these individuals into never-ending cycles.  The second overarching 
concern among patients with IBS was isolation, meaning no feelings of belongingness 
among coworkers, family, or friends, feeling as though they are experiencing IBS alone 
with a lack of support, and viewing their symptoms of IBS as embarrassing.  This 
isolation was also perceived in the workplace due to having to go to the bathroom 
frequently and miss many days of work because of symptoms.  The third concern was 
avoidance of social events due to these feelings of embarrassment, with recurrent use of 
the bathroom and the various symptoms of IBS, such as gas, bloating, abdominal pain, 
and diarrhea (Bertram, Kurland, Lydick, Locke, & Yawn, 2001). 
 Being that the IBS patient experiences many difficulties and stress related to his 
or her support system and daily activities, health care experiences with the physician is 
extremely important.  Due to the first health care contact often being the general 
practitioner or family medicine physician, the general physician is a vital part of an IBS 
patient’s experiences, whether a positive or negative.  A patient’s previous experiences 
can also affect how he or she perceives the health care process and treatment, and can 
influence how IBS is handled in the future (Dhaliwal & R. H. Hunt, 2004).  Many 
individuals with IBS hold negative attitudes toward their physicians because of a 
perceived lack of understanding, limited confidence in their physicians, and feelings of 
frustration with their physicians (Bertram et al., 2001; Meadows, S. Lackner, & Belic, 
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1997; Stenner et al., 2000).  Conversely, Stenner, Dancey, and Watts (2000) found that 
IBS patients trust their physicians and believe them to be knowledgeable about IBS.  This 
is due to the patients in their study perceiving IBS as being caused by stress in their lives, 
as well as viewing that their physicians agree that IBS is also due to stress (Stenner et al., 
2000).  
 Physician perspectives of IBS.  Most research has targeted IBS patients seeing a 
gastroenterologist, even though the majority of IBS patients are provided care in family 
medicine and/or primary care settings (Bertram, Kurland, Lydick, Locke, & Yawn, 
2001).  In one study, there was limited knowledge among family practitioners about IBS 
regarding some important symptomatology, lowered satisfaction caring for IBS patients, 
a lack of confidence caring for IBS patients, and reported difficulty satisfying IBS 
patients.  In this same study, after the physicians completed the measures and pretests, 
some of the physicians took a two-hour educational course, consisting of a 1.5-hour 
lecture about IBS and 30 minutes of discussion and questions.  This study found that 
despite knowledge of IBS slightly increasing, attitudes toward IBS were unchanged, even 
after the two-hour educational course (Longstreth & Burchette, 2003).   
Another FGID, inflammatory bowel disease (IBD), has been compared with IBS 
with regards to the perceptions of gastroenterologists and nurses.  The gastroenterologists 
in the study perceived IBD to be more severe than IBS, and believed that IBD patients 
have a better comprehension of their condition compared to IBS patients.  In this same 
study, the gastroenterologists were found to believe that treatment helped IBD more than 
IBS patients; however, these gastroenterologists also indicated believing that IBS patients 
have more control over their condition than IBD patients, possibly being due to IBS 
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being related to psychosomatic factors.  Further, the nurses in this study believed that 
IBD patients understand their condition better than IBS patients, and endure more severe 
consequences than IBS patients (Dickman et al., 2011).  Also, a study that compared 
gastroenterologists and IBS patients found that between patients with IBS and 
gastroenterologists, patients considered psychological contributing factors more than the 
gastroenterologists (S. Levy et al., 2014).   
Despite the differing perceptions among physicians depending on which diagnosis 
each patient presents with, knowledge among physicians regarding IBS differs as well.  
Among 36 family practitioners in a study conducted by Longstreth and Burchette (2003), 
35% of physicians were knowledgeable of the Manning and Rome Criteria and 49% of 
these physicians could name only the typical IBS symptoms and the Rome II Criteria 
(Longstreth & Burchette, 2003).  Further, the majority of primary care physicians have 
been found to believe IBS is a “diagnosis of exclusion;” however, most also referred for 
additional testing in order to make an IBS diagnosis (Lacy et al., 2006).  Further, the 
majority of these physicians did not know that CBT is an effective treatment regimen for 
IBS.  In addition, family practitioners reported more difficulty deciding on treatment for 
IBS patients compared to making treatment recommendations for patients with other 
painful diagnoses, and these physicians reported needing more time to care for IBS 
patients.  This limited knowledge about the typical IBS symptomatology and diagnostic 
criteria can hinder quality of care for IBS patients (Longstreth & Burchette, 2003).  
Another study found similar results regarding physicians’ knowledge about utilizing the 
Rome II Criteria for diagnosing IBS.  Among 28 general practitioners surveyed, 17 stated 
they believed that they did not have enough knowledge to diagnose IBS, but three of 
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those 17 stated that more education would be helpful.  Ten of the 28 general practitioners 
surveyed did not know about the Rome II Criteria and three reported using the Rome II 
Criteria to diagnose IBS.  Although many of these physicians reported unfamiliarity with 
the Rome II Criteria, they correctly identified the main criteria for diagnosing IBS 
(Bellini et al., 2005).   
In the same Italian study, psychological causes were viewed as the second most 
important reason for IBS to develop; however, 11.4% of the 36,418 patients surveyed in 
the same study were referred to psychologists or psychiatrists.  Many of these physicians 
prescribed large amounts of antidepressants and anxiolytic medications to their patients 
with IBS.  Many of these physicians also discussed diet and lifestyle changes with their 
IBS patients and provided advice regarding how to cope with the diagnosis (Bellini et al., 
2005).  Nevertheless, due to IBS often being considered a diagnosis of exclusion, this can 
often cause a difference in treatment by health care professionals.  In one study by 
Spiegel, Farid, Esrailian, Talley, and Chang (2010), they found that when comparing IBS 
expert health care professionals to gastroenterologists, primary care physicians, and nurse 
practitioners, the IBS experts were more likely to diagnose someone with IBS and used 
less diagnostic tests, whereas the “non-expert” health care professionals were more likely 
to consider IBS a diagnosis of exclusion.  Therefore, health care professionals who were 
not considered IBS experts were more likely to order diagnostic tests for patients and, 
thus, spent more money on diagnosing patients with IBS.  IBS experts seemed to follow 
the diagnostic guidelines more compared to the “non-expert” health care professionals 
(Spiegel, Farid, Esrailian, Talley, & Chang, 2010).  Additionally, in another study that 
compared the perceptions of gastroenterologists, internal medicine physicians, and family 
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practice physicians, perceptions about IBS differed based on medical specialty.  
Gastroenterologists gave an IBS diagnosis more times a week compared to internal 
medicine and family practitioner physicians.  Also, even though gastroenterologists 
responded to needing more appointment time for IBS patients compared to other 
physicians, gastroenterologists also viewed IBS patients as “less sick” compared to the 
views of internal medicine and family practitioner physicians.  Family practitioner 
physicians believed nutrition and diet as the cause of IBS, whereas gastroenterologists 
indicated an abuse history and prior infection as the main causes of IBS.  Further, 
gastroenterologists were less likely to refer patients for more diagnostic tests, and instead 
gave definite IBS diagnoses.  On the other hand, internal medicine and family medicine 
physicians indicated that about one third of IBS patients should be referred to a 
gastroenterologist for further testing and care (Lacy et al., 2006).    
Research Questions 
Two questions were explored through the present study: (a) Do family medicine 
physicians and IBS patients hold negative attitudes about IBS?  (b) Is there a lack of 
knowledge about IBS among family medicine physicians and IBS patients? 
Purpose of the Study 
Research has reported that physician attitudes about IBS tend to differ and can be 
more negative due to a lack of knowledge about IBS and evidenced-based treatments 
(Heitkemper et al., 2002; Lacy et al., 2007).  The purpose of this study was to determine 
whether there is a lack of knowledge about IBS and whether there are negative attitudes 
toward IBS among family medicine physicians and among patients diagnosed with IBS.  
Results of this study may provide more information about whether more training and 
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education is needed within a medical school setting, as well as whether continuing 
medical education is needed for physicians.  This study also aimed to provide information 
about differences in knowledge about IBS between family medicine physicians and IBS 
patients, and whether IBS patients need more education about IBS from their physicians 
and other medical professionals.  This study examined whether IBS patients are also 
being educated about and offered specific evidence-based treatments.  Finally, this study 
examined attitudes among family medicine physicians and patients diagnosed with IBS, 
as well as whether there are significant differences between both populations. 
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Chapter 2: Hypotheses 
 Two hypotheses were proposed based on a thorough review of the literature. 
Hypothesis 1 
It was hypothesized that IBS patients would have more positive attitudes toward 
IBS compared to family medicine physicians.  
Hypothesis 2 
It was hypothesized that family medicine physicians would display more general 
knowledge compared to IBS patients.  
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Chapter 3: Method 
Design and Design Justification 
This study was a cross-sectional survey design.  There are costs and benefits to 
this research design.  The costs of a cross-sectional survey design include selection bias, 
inability to infer a causal relationship between variables, and a lack of generalizability to 
from a specific population to other populations.  The benefits of a cross-sectional survey 
design include its cost effectiveness and having more control.  This design was chosen 
because the purpose of this study was to make inferences about the populations, family 
medicine physicians and IBS patients, by examining the sample at a specific point of time 
in order to gather data about whether attitudes and the amount of knowledge have 
changed compared to previous research.  It utilized an online survey through the forum 
SurveyMonkey. 
Participants   
241 IBS patients and 87 physicians were recruited to participate in this study, and 
of these, 175 IBS patients and 41 family medicine physicians were eligible to participate 
and completed all of the questionnaires.  Of the family medicine physician participants, 
53.7% (n = 22) were allopathic (MD) family medicine physicians, 46.3% (n = 19) were 
osteopathic (DO) family medicine physicians, 43.9% (n = 18) were attendings, and 
56.1% (n = 23) were residents.  Of the adult patients who were diagnosed with IBS, 33 
(18.9%) were male, 139 (79.4%) were female, 1 (0.6%) was gender fluid, and 1 (0.6%) 
was non-binary.  Ages of the physicians ranged from 26 to 65 years old, with a mean age 
of 33.7, and ages of IBS patients ranged from 18 to 77 years old, with a mean age of 29.8. 
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Inclusion criteria.  Eligible physician participants graduated from allopathic 
program (MD) or an osteopathic programs (DO) in the United States, were either 
currently in family medicine residency, fellowship, or working as attending physicians in 
family medicine settings (i.e., an office that provides the first point of contact for a 
patient and provides a personalized physician for each patient and family).  Eligible non-
physician participants included individuals with IBS diagnoses. 
Exclusion criteria.  Individuals were excluded if they did not hold medical 
degrees from allopathic program (MD) or osteopathic programs (DO) in the United 
States.  This included exclusion of students in medical school who had not yet graduated 
at the time of the study.  Additionally, individuals were excluded if they did not practice 
family medicine and in family medicine settings.  
In addition to exclusions of individuals in the medical field, non-physician 
individuals were excluded if they were not diagnosed with IBS from family medicine 
physicians, gastroenterologists, or internal medicine physicians and if they were under 
the age of 18.  If a patient was diagnosed with IBS from a physician who is not a family 
medicine physician, a gastroenterologist, or an internal medicine physician, then he or 
she was excluded from the study.  
Recruitment 
Participants were recruited by the distribution of the survey link through social 
media sites, such as Facebook and Reddit (see Appendix D).  The survey was also e-
mailed to the Philadelphia College of Osteopathic Medicine (PCOM) community through 
the PCOM Help Desk e-mail listserv.  A chance to win a $50 Amazon gift card was 
offered through a raffle in exchange for completing the survey.  At the end of the survey, 
IBS ATTITUDES AND KNOWLEDGE   37
participants were provided with a separate e-mail address to e-mail in order to enter their 
names into the raffle.  The participants’ names entered into the raffle could not, therefore, 
be connected with their survey responses.    
To ensure eligibility, screening procedures for family medicine physicians 
included a demographic form in the beginning of the survey measure inquiring about 
medical degree, graduation year from medical school, subfield of medicine, area of 
interest, job title, age, gender, general practice location, and inquiry regarding personal 
connections to IBS.  Due to anonymity for participants in this study, specific places of 
work and specific medical schools attended were not asked.   
Screening procedures to ensure eligibility for IBS patients included a 
demographic form in the beginning of the survey measure inquiring about age, race, 
gender, number of years diagnosed with IBS, type of physician who diagnosed the patient 
with IBS, symptoms experienced, subtype of diagnosed IBS if known, current 
medications, and whether each patient was participating in other types of IBS treatment, 
such as meeting with a nutritionist, psychotherapy, acupuncture, and/or massage therapy. 
Measures 
Demographic questionnaires.  Questionnaires inquired about demographic 
information in order to determine whether eligibility criteria were met.  A physician 
demographic questionnaire was provided to the physicians and a patient demographic 
questionnaire was provided to IBS patients.  The physician demographic questionnaire 
consisted of 14 questions and the IBS patient demographic questionnaire consisted of 11 
questions.  The physician questionnaire inquired about gender, age range, ethnicity, 
religion, degree completed, type of physician, where the physician stands in his or her 
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training and profession, number of years practicing medicine, practice location type, past 
educational experiences about FGIDs, and if the physician or anyone else he or she 
knows has IBS.  The patient demographic questionnaire inquired about gender, age 
range, ethnicity, religion, marital status, years of being diagnosed with IBS, type of 
physician that gave the diagnosis, type of IBS diagnosed, and past and current used 
treatments.  The demographic questionnaires for patients and physicians can be found in 
Appendix A and Appendix B, respectively.   
The Revised Illness Perception Questionnaire.  The Revised Illness Perception 
Questionnaire (IPQ-R), which was adapted for family medicine physicians and IBS 
patients, is a 70-item questionnaire (Moss-Morris et al., 2002).  The IPQ-R for physicians 
was obtained from a study by S. Levy et al. (2014), which was conducted in Israel.  
Therefore, the version of the IPQ-R used in this study was originally in Hebrew.  The 
questionnaire was translated to English and back translated to Hebrew, to ensure accurate 
translation.   
The questionnaire was originally adapted to assess a patient’s perception of an 
illness.  An individual’s illness perception shows the emotional response and cognitive 
processes about an illness that can affect health adherence behaviors for that illness.  
Specifically, illness perceptions are “mental representations and personal ideas people 
have about their illness” (Broadbent et al., 2015, p. 1362).  An individual’s perception 
about an illness consists of five domains: (a) beliefs about identity of illness (name and 
symptoms), (b) causes, (c) illness consequences, (d) timeline of illness or how it 
progresses, and (e) how illness can be controlled or healed (Broadbent et al., 2015; Lau, 
Bernard, & Hartman, 1989; Petrie & Weinman, 2012).  This conceptualization derives 
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from Leventhal’s self-regulatory model (Leventhal, Nerenz, & Steele, 1984).  
Leventhal’s self-regulatory model states that an individual attempts to form his or her 
“illness representation” or comprehension of his or her illness by trying to understand 
what the illness actually is, its meaning, its consequences, its cause(s), its length or 
course, and if it can be cured or managed (Leventhal et al., 1984).  An individual’s illness 
representation is not formed by scientific evidence, but derives from his or her 
experiences of the illness, including symptoms, emotions related to illness, social 
influences, and relationship with physicians and other health care providers.  Therefore, 
adherence to health behaviors and how an individual copes with an illness is affected by 
his or her illness representation, views, and experiences of that illness (Leventhal et al., 
1984).  
  The IPQ-R is divided into three sections.  The first section asks to identify 
specific symptoms of the illness of interest and whether the participant experiences the 
specific symptoms.  The second section uses a 5-point Likert scale and inquires about the 
respondent’s views about the illness, which include emotional components, 
consequences, and whether the illness is cyclical, chronic, or acute.  The third section of 
the measure also uses a 5-point Likert scale and asks about the participant’s perceptions 
about the causes of his or her illness (Moss-Morris et al., 2002).  For the purpose of this 
study, 38 items from the second and third sections, the Views About my Illness scale, 
were used.  The first section inquiring about the specific symptoms experienced by the 
participant was excluded.  Therefore, participants in this study were asked to respond to 
38 items from the IPQ-R.  The 38-items are divided into seven subscales: Timeline 
(Acute/Chronic), Consequences, Personal Control, Treatment Control, Illness Coherence, 
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Timeline-Cyclical, and Emotional Representations.  The Timeline (Acute/Chronic) 
subscale asks about how long the individual thinks the illness will last (acute versus 
chronic), whereas the Timeline-Cyclical subscale asks about an individual’s beliefs about 
the cyclical nature of the illness.  The Consequences subscale looks at the expectations 
the person has and the effects the person believes the illness will have.  The Personal 
Control and Treatment Control subscales ask about perceptions of control over the illness 
through treatment (treatment) and how the individual recovers from the illness and its 
symptoms (personal).  The factor of control, whether treatment control or personal 
control, plays an important role.  If the individual perceives that he or she can control or 
cure the illness, this is associated with a perception of the illness not lasting a long time 
and as causing more minor consequences.  The Illness Coherence subscale was added to 
the revised version of the IPQ.  This subscale explores whether an individual’s 
perceptions provide a clear, accurate understanding of the illness.  The Emotional 
Representations subscale looks at the emotional reactions and responses caused by the 
illness.  This particular subscale was added to the revised version of the IPQ after Moss-
Morris et al. (2002) found the original IPQ only studied the cognitive responses from an 
illness and not the emotional components of an illness (Moss-Morris et al., 2002).   
 The IPQ-R has been adapted for various illnesses, such as asthma, acute pain, 
chronic pain, autism, diabetes, fatigue, hemophilia, human immunodeficiency virus 
(HIV), hypertension, genetic predisposition, sexually transmitted disease (STD), and 
rheumatoid arthritis.  The IPQ-R has been translated into 17 other languages.  The IPQ-R 
subscales have good internal reliability, particularly on the Identity subscale, which has a 
Cronbach’s alpha of .75.  The test-retest reliability shows to be consistent over three 
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weeks and six months.  The known group validity for the IPQ-R between chronic pain 
and acute pain patients is also effective, as the scale was able to differentiate between the 
two groups on all of the factors being studied (Moss-Morris et al., 2002).  Tables 1 
through 3 include sample items from each subscale of the IPQ-R. 
 
 
Table 1 
Personal Control and Treatment Control Subscale Items     
Personal Control Items Treatment Control Items 
There is a lot an IBS patient can do to 
control IBS symptoms.   
There is very little that can be done to 
improve IBS. 
What an IBS patient does can determine 
whether IBS will get better or worse. 
An IBS patent’s treatment of IBS will 
be effective in curing IBS. 
The course of IBS depends on the IBS 
patient. 
The negative effects of IBS can be 
prevented (avoided) by treatment. 
 
 
Table 2 
Timeline (Acute/Chronic), Emotional Representation, and Illness Coherence Subscale 
Items  
 
Timeline (Acute/Chronic) 
Items 
Emotional Representation 
Items 
Illness Coherence Items 
IBS will last a short time. IBS can cause an IBS patient 
to get depressed. 
The symptoms of IBS are 
puzzling. 
IBS is likely to be permanent 
rather than temporary. 
IBS can cause an IBS patient 
to get upset. 
IBS is a mystery to me. 
IBS will last for a long time. IBS can make an IBS patient 
feel angry. 
I don’t understand IBS. 
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Table 3 
Timeline-Cyclical and Consequences Subscale Items  
Timeline-Cyclical Items Consequences Items 
The symptoms of IBS change a great deal 
from day to day. 
IBS is a serious condition. 
IBS symptoms come and go in cycles.  IBS has major consequences on a 
person’s life. 
IBS is very unpredictable. IBS does not have much effect on a 
person’s life. 
 
 
 
Knowledge questionnaire.  A questionnaire testing participants’ general 
knowledge of IBS was provided.  It was designed using a true-false format.  The 
knowledge questionnaire consisted of 14 items inquiring about IBS in general, IBS 
symptoms, treatment options, and diagnostic criteria.  The knowledge questionnaire was 
created specifically for this study and based on the Rome IV diagnostic criteria.  The 
same questionnaire was used with both IBS patients and family medicine physicians.  
The knowledge questionnaire utilized in this study can be found in Appendix C.  
Procedure 
The study took approximately 15 to 20 minutes for participants to complete.  The 
questionnaires were uploaded into SurveyMonkey.com.  Two separate surveys were 
created on SurveyMonkey, one survey and link for family medicine physicians and one 
survey and link for individuals with IBS.  Potential participants received the 
SurveyMonkey.com link, which led to a page explaining the study, confidentiality, and 
informed consent to participate in the study.  The survey was also posted on social media 
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through Facebook and Reddit, with an explanation of the study and indicating which link 
was aimed toward IBS patients and which was aimed toward physicians.  Participants 
were notified before participating and completing the measures that the study was 
anonymous and they could withdraw from the study at any time.  Participants were also 
offered to enter a drawing for a $50 gift card from Amazon.  Participants first completed 
the required eligibility questions, aimed toward the inclusion criteria.  If the participants 
were eligible for the study, they were then directed to complete the demographic form, 
followed by the IPQ-R and the knowledge questionnaires.  At the end of the survey, after 
the participant completed the entire survey, he or she provided with a separate Gmail 
address (ibspcomstudy@gmail.com) to e-mail if interested in entering the raffle to win 
the gift card.  
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Chapter 4: Results 
This study examined differences between family medicine physicians’ and IBS 
patients’ attitudes toward and knowledge of IBS.  A depiction of physician participant (n 
= 41) demographic information is presented in Table 4.  Demographic information for 
non-physician participants (n = 175) is shown in Table 5. 
 
   
Table 4 
Demographic Analysis – Family Medicine Physicians (n = 41)  
 Frequency Percent 
Gender Male 18 43.9 
Female 23 56.1 
Ethnicity African American 1 2.4 
Caucasian 36 87.8 
Asian & Pacific 
Islander 
3 7.3 
Middle Eastern 1 2.4 
Religion Christian 18 43.9 
Jewish 6 14.6 
Hindu 1 2.4 
Agnostic 7 17.1 
Atheist 2 4.9 
None 7 17.1 
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Degree Type Doctor of 
Osteopathic 
Medicine (DO) 
 
19 
 
46.3 
 
Doctor of Medicine 
(MD) 
22 53.7 
Level of Training Resident 23 56.1 
Attending 18 43.9 
Practice Location Urban 12 29.3 
Rural 7 17.1 
Suburban 22 53.7 
Typical 
Recommended 
Treatments for IBS 
Medication based 
on symptoms 
35 85.4 
 
Psychotropic 
Medication 
13 31.7 
 
Psychotherapy 4 9.8 
Physical Exercise 14 34.1 
Attendance of 
IBS/FGID 
conferences, 
seminars, trainings 
in last 5 years 
Yes 8 19.5 
No 33 80.5 
Do you have IBS? Yes 11 26.8 
No 30 73.2 
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Personally know 
anyone (family 
member, close 
friend, etc.) with 
IBS 
No 22 53.7 
Yes 19 46.3 
 
 
 
 
 
Table 5 
Demographic Analysis – IBS Patients (n = 175) 
 Frequency Percent 
Gender Male 33 18.9 
Female 139 79.4 
Non-Binary 1 0.6 
Gender Fluid 1 0.6 
Ethnicity African American 2 1.1 
Caucasian 154 88.0 
Asian or Pacific 
Islander 
6 3.4 
Spanish, Latino, or 
Hispanic American 
4 2.3 
 
Native American 
or Alaskan Native 
1 0.6 
North African 2 1.1 
Biracial or Mixed 
Race 
6 3.4 
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Religion Christian 59 33.7 
Islam 2 1.1 
Jewish 17 9.7 
Hindu 1 0.6 
Agnostic 22 12.6 
Atheist 26 14.9 
None 44 25.1 
Other 3 1.7 
Marital Status Married 45 25.7 
Divorced 2 1.1 
Widowed 3 1.7 
Not married, in 
relationship 
 
64 36.6 
Not married, nor in 
relationship 
62 35.4 
Type of physician 
that diagnosed you 
with IBS 
Family Medicine 51 29.1 
Gastroenterologist 113 64.6 
Internal Medicine 11 6.3 
IBS Type IBS-Constipation 32 18.3 
IBS-Diarrhea 83 47.4 
IBS-Mixed 45 25.7 
IBS-Unspecified 12 6.9 
Unknown 3 1.7 
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Use medications or 
vitamins to treat 
IBS 
Yes 120 68.6 
No 55 31.4 
Use alternative 
treatments to treat 
IBS (exercise, yoga, 
relaxation, 
psychotherapy, etc.) 
Yes 94 53.7 
No 81 46.3 
 
 
 
Hypothesis 1 
Hypothesis 1 stated that IBS patients would have more positive attitudes toward 
IBS compared to family medicine physicians.  To compare the attitudes of IBS patients 
and family medicine physicians regarding IBS, a multivariate analysis of variance 
(MANOVA) was conducted.  A MANOVA requires correlation between the dependent 
variables.  To test this, an intercorrelation matrix of all of the dependent variables was 
created and it was determined that out of the seven variables, two of them were correlated 
with each other and five of the other variables were correlated with each other.  This 
necessitated two separate MANOVA analyses.  In the first analysis, a comparison was 
made between two levels of the independent variable (family medicine physicians and 
IBS patients) and two dependent variables: the subscales of Treatment Control and 
Personal Control.  Box’s test of equality of covariance matrices was conducted and found 
to not be significant, Box’s M = 4.796, F(3,71934) = 1.568, p = .195.  The Box’s Test is 
designed to evaluate the hypothesis that the observed covariance matrices of the 
dependent variables are equal across groups.  This analysis revealed that the observed 
covariance matrices of the dependent variables were equal across groups.  The 
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multivariate test revealed a significant difference between groups, Wilks’ Lambda = .912, 
F(2,213) = 10.249, p = .000.  The Levene’s test of equality of error variances revealed 
there were no significant differences in variances across the groups on the two dependent 
variables.  The test of between-subjects effects revealed a significant difference on the 
Personal Control total score, F(214) = 16.14, p = .000, partial eta squared = .07.  An 
examination of the means revealed that the IBS patients scored significantly higher than 
the family medicine physicians on Personal Control.  Table 6 illustrates the descriptive 
statistics for these two groups on the dependent variable of Personal Control. 
 
 
 
Table 6 
Personal Control Descriptive Statistics 
Personal Control Total 
Score 
Mean Standard Deviation 
IBS Patients 14.080 2.847 
Family Medicine Physicians 12.146 2.424 
 
 
A second MANOVA was conducted using group membership as the independent 
variable with two levels (IBS patients and family medicine physicians) and five 
dependent variables that were found to be correlated with each other, including the 
subscales of Timeline (Acute/Chronic), Consequences, Illness Coherence, Emotional 
Representation, and Timeline-Cyclical.  In this instance, however, Box’s test of equality 
of covariance matrices was significant, Box’s M = 55.835, F(15,20726.8) = 3.547, p = 
.000.  This analysis revealed a violation of the assumption of the equality of covariance 
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matrices.  According to Field (2013), with a MANOVA, it is assumed that the variances 
in each group are roughly equal.  This is tested by examining whether the population, or 
covariance matrices of the comparison groups, are equal.  The effect of violating the 
assumption of equality of covariate matrices remains unclear, although, Field argued that 
Hotelling T-squared “is robust in the two sample situations when sample sizes are equal” 
(p. 194).  In large samples, Box’s test could be significant even when the covariance 
matrices are homogenous.  As Field reported, “as a general rule, if sample sizes are equal 
then people tend to disregard Box’s Test, because (1) it is unstable, and (2) in this 
situation we can assume that Hotelling’s and Pillai’s statistics are robust” (p. 643).  In 
contrast, if group sizes are different, robustness cannot be assumed.  In this instance, as 
Field noted, the more dependent variables measured, and the greater the differences in 
sample sizes, the more distorted the results may be.  One alternative suggested by Field is 
to equalize the samples through randomly eliminating cases in the larger group.  In any 
case, the results of the overall analysis should be made with caution.  The results of the 
multivariate test revealed a significant difference between groups, Pillai’s Trace = .234, 
F(5,210) = 12.79, p = .000.  Similar results were found for Wilks’ Lambda, Hotelling’s 
Trace, and Roy’s Largest Root.  For example, Hotelling's Trace was found to be equal to 
.305, F(5,210) = 12.79, p = .000.  In examining the Levene’s test of the equality of error 
variances, there was heterogeneity of variance on the illness coherence total score only 
across the groups.  This test evaluates the hypothesis that the variances of the set of 
variables are equal across groups.  When evaluating Levene’s test, Field noted “the test(s) 
of homogeneity of variance like Levene’s tend to work very well when you have equal 
group sizes and large samples and don’t work as well with unequal group sizes and 
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smaller samples” (p. 194).  Therefore, due to the large sample size, the Levene’s test is 
more likely to show significance, which is demonstrated with the Illness Coherence 
subscale.  The test of between-subjects effects revealed significant differences between 
the groups on Illness Coherence (F(1,214) = 26.62, p = .000), Timeline (Acute/Chronic; 
F(1,214) = 37.11, p = .000), and Emotional Representation (F(1,214) = 9.395, p = .002).  
Comparison of the groups revealed that the physicians scored significantly higher on 
Timeline (Acute/Chronic) compared to the patients (patient mean = 11.177 vs. physician 
mean = 14.634).  On Illness Coherence, the patients scored significantly higher than the 
physicians (patient mean = 16.491 vs. physician mean = 12.390) and on Emotional 
Representation, the physicians scored significantly higher than the patients (patient mean 
= 8.977 vs. physician mean = 10.561).  Descriptive statistics can be found in Table 7.   
 
 
Table 7 
Timeline (Acute/Chronic), Illness Coherence, Emotional Representation Descriptive 
Statistics 
 
Subscales Participants Mean Standard Deviation 
Timeline 
(Acute/Chronic) 
Patients 
 
Physicians 
11.177 
 
14.634 
3.299 
 
3.145 
Illness Coherence Patients 
 
Physicians 
16.491 
 
12.390 
4.842 
 
3.208 
Emotional 
Representation 
Patients 
 
Physicians 
8.977 
 
10.561 
2.986 
 
2.942 
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Hypothesis 2 
Hypothesis 2 stated that family medicine physicians would display more general 
knowledge compared to IBS patients.  Findings suggest no significant difference between 
these groups.  To evaluate this hypothesis, an independent groups t-test was conducted.  
A Levene’s test for the equality of variances revealed that equal variances could not be 
assumed (F = 6.218, p = .013).  To adjust for this, a t-test for equal variances not assumed 
was conducted, t(85.91) = 1.409, p = .162.  Table 8 depicts the results of this t-test, and 
Table 9 illustrates the group statistics.  
 
 
Table 8 
Knowledge – Independent Samples Test 
Knowledge Total Score Df Sig. (2-tailed) Mean 
Difference 
Equal variances assumed 214 .266 .305 
Equal variances not assumed 85.913 .162 .305 
 
 
Table 9 
Knowledge – Group Statistics  
Knowledge Total Score N Mean Std. Deviation 
IBS Patients 175 10.085 1.663 
Family Medicine Physicians 41 9.780 1.129 
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Chapter 5: Discussion 
 This study examined differences between attitudes regarding IBS among family 
medicine physicians and individuals with IBS.  Further, this study sought to identify 
differences in the amount of knowledge between family medicine physicians and IBS 
patients.  This study can help explain the reported difficulties between family medicine 
physicians and IBS patients, as IBS patients often report feeling misunderstood and not 
heard by their physicians.  Conversely, physicians report feeling frustrated with their IBS 
patients due to the difficulty of treating IBS and IBS having an unclear etiology (Chang 
et al., 2006; Lacy et al., 2007).  If all of the hypotheses had been accepted, it would 
suggest that IBS patients would have more positive attitudes toward IBS compared to 
family medicine physicians and family medicine physicians would have more general 
knowledge about IBS compared to IBS patients.  This study found that Hypothesis 1, that 
IBS patients would demonstrate more positive attitudes toward IBS compared to family 
medicine physicians, was accepted, based on five of the seven attitudes subscales being 
significant, with four of those five subscales showing overall more negative attitudes 
among family medicine physicians.  Regarding Hypothesis 2, stating that family 
medicine physicians would display more knowledge about IBS compared to IBS patients, 
the null was retained based on no significant differences found between the two groups’ 
responses on the knowledge measure.  
Attitudes 
Personal control and treatment control.  According to the results of this study, 
patients perceive more personal control over their IBS compared to what family medicine 
physicians perceive.  In regard to the factor of control, the more control an individual 
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perceives, the more that individual believes he or she can cure or control the illness to the 
extent that it does not have major effects on his or her life.  The fact that IBS patients 
often feel misunderstood by their physicians (Taft et al., 2011) suggests that physicians 
may feel less control over IBS, possibly because IBS is difficult to treat due to its unclear 
etiology (Bellini et al., 2005; Dixon-Woods & Critchley, 2000).  Due to the Treatment 
Control subscale showing no significance in this study, the fact that Personal Control 
demonstrated significance may also suggest that physicians feel more pessimistic 
regarding IBS and may, therefore, be more influenced by their own emotions when 
treating their IBS patients.  In contrast, previous research suggests that IBS patients feel a 
lack of control over their lives, due to the unpredictability of IBS and its symptoms 
(Chang et al., 2006).  An explanation for this discrepancy may be that IBS patients 
reported a perception of more control over IBS compared to the family medicine 
physicians because, typically, IBS patients will present to their physicians during flare 
ups of their IBS symptoms.  This means that physicians are more likely to see IBS 
patients when they are not doing well, causing the perception of IBS for physicians to be 
more pessimistic and more out of control.   
Emotional representation.  The Emotional Representation variable studies the 
emotional reactions and responses caused by IBS.  This study found that the family 
medicine physicians rated the emotional effects and reactions from IBS as higher 
compared to the IBS patients.  This shows that family medicine physicians tend to 
believe that IBS will cause more negative emotions—including depression and anxiety—
than IBS patients believe.  This result displays a more negative attitude among family 
medicine physicians due to the physicians believing that IBS will cause more negative 
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emotions for a patient, even though IBS patients seem to disagree and did not rate this 
scale as highly.  This difference in belief between family medicine physicians and IBS 
patients supports the research that physician attitudes tend to differ and be more negative, 
due in part to a lack of knowledge about IBS (Heitkemper et al., 2002; Lacy et al., 2007).  
A possible solution to family medicine physicians perceiving more negative emotions 
associated with IBS is to have more integration of behavioral health in family medicine.  
For example, psychologists and/or behavioral health consultants on staff in medical 
practices would not only help IBS patients receive more evidenced-based treatment, such 
as CBT for IBS, but also help lessen physicians’ frustration and stress related to treating 
IBS.  This can also help improve the patient-physician relationship, thus improving 
patients’ adherence to treatment and physicians’ attitudes toward IBS (Chang et al., 
2006).  Keefer, Palsson, and Pandolfino (2018) outlined the benefits of incorporating 
psychogastroenterology into practice, such as having a behavioral health consultant 
and/or psychologist on staff trained on brain-gut therapies to provide evidenced-based 
treatments to patients with brain-gut disorders such as IBS.  This is shown to significantly 
improve an IBS patient’s quality of life (Keefer, Palsson, & Pandolfino, 2018).   
Timeline (acute/chronic).  The Timeline (Acute/Chronic) subscale of whether 
the participants believe IBS is acute or chronic and if it will last a long time or short time 
showed significant differences between the two groups.  Family medicine physicians 
rated this subscale higher than the IBS patients, showing that family medicine physicians 
perceive IBS to be more chronic compared to the IBS patients’ perceptions.  Conversely, 
the IBS patients did not rate IBS as long-lasting.  This may be due to IBS being 
considered a chronic condition within the medical field; however, there are known 
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alternative treatments that align more with the biopsychosocial model of care rather than 
the medical model of care that may provide hope to IBS patients that the course of the 
illness may not be chronic.  IBS patients in this study (n = 175) responded on the 
demographic questionnaire that for alternative IBS treatments, they use yoga, meditation, 
mindfulness/relaxation techniques, deep breathing/progressive muscle relaxation, 
nutrition (practicing good nutrition in general, or making more specific changes in diet, 
including FODMAP, vegan, plant-based, and/or gluten-free diets), physical exercise, 
biofeedback, peppermint and detox teas, CBD/peppermint/fish oils, psychotherapy/CBT, 
grapefruit seed extract, and aloe vera juice.  These specific responses demonstrate that 
IBS patients report utilizing more biopsychosocial treatments compared to the traditional 
medical model treatments, such as solely using medication to treat IBS symptoms.   
Illness coherence.  Despite family medicine physicians scoring higher on 
perceptions of more negative emotions, more chronicity, and perceiving less control over 
IBS, family medicine physicians also demonstrated more understanding of IBS compared 
to IBS patients.  Therefore, IBS patients rated the Illness Coherence variable higher; thus, 
they feel more confused and more puzzled by their own conditions.  IBS can be an 
unpredictable condition with no biological marker (Chang et al., 2006), while being 
bidirectional with one’s emotional/mental health and gut health (Drossman, 2016).  These 
factors, which play a major role with IBS and the expression of IBS symptoms, can often 
make IBS a mystery to individuals suffering with it.  This was an interesting finding due 
to IBS patients perceiving more control over their condition even though they perceive 
IBS to be more of a mystery.  This may be due to the fact that IBS has an unclear 
etiology, and patients have to go through various diagnostic tests to exclude other 
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possible conditions before being diagnosed officially with IBS.  This makes the 
syndrome more of a mystery in regard to why it develops, where it derives from, and how 
to treat it effectively.  Notably, the sample of IBS patients who were surveyed in this 
study were recruited from social media outlets and various support groups on these social 
media outlets, meaning this sample may be involved in finding alternative effective 
treatments by communicating with other individuals with IBS.  This relates then to a 
perception of more control over the illness, due to feeling more support from these 
various social media groups and utilizing these alternative treatments for the various 
symptoms.   
Consequences and timeline-cyclical.  The subscale Consequences, which studies 
the expectations and effects the individual believes IBS will have on him or her, 
presented no significant differences between IBS patients and family medicine 
physicians.  The Timeline-Cyclical subscale, which measures the perceptions of the 
cyclical nature of IBS, also showed no significant differences between family medicine 
physicians and IBS patients.  
Attitudes conclusions.  Patients feel more in control of their IBS, perceive less 
negative emotions associated with their conditions, and perceive IBS to not be as long-
lasting compared to family medicine physicians.  Further, family medicine physicians 
believed that they have a clearer and more accurate understanding of IBS compared to 
IBS patients.  These results can have significant implications regarding overall attitudes 
of IBS and, therefore, can affect the patient-physician relationship, perception of stigma 
and feeling understood, and confidence in oneself or confidence in ability to treat IBS.  
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Knowledge  
 It was found that family medicine physicians and IBS patients did not differ on 
their amount of knowledge, according to the 14-item knowledge questionnaire results.  
This means that family medicine physicians displayed the same amount of knowledge as 
IBS patients in this study.  This may mean that family medicine physicians and medical 
school students specializing in family medicine need more training and education about 
IBS and FGIDs in general, due to the expectation that physicians should have more 
knowledge about IBS in order to treat their patients effectively.  These results also may 
explain physician frustration and perceived stigma often felt by IBS patients (Bellini et 
al., 2005).  The family medicine physicians and IBS patients in this sample may have the 
same amount of knowledge due to the IBS patients being recruited from social media 
outlets and various support groups on these social media websites, meaning these patients 
are more likely to be doing their own research about IBS and possible alternative 
treatments.  Therefore, this patient sample may be more knowledgeable than if the IBS 
patients were recruited from other outlets.  Another explanation for the two groups 
having similar scores on the knowledge questionnaire is the true/false format of the 
measure.   
Limitations 
Power.  This study has a small sample size of family medicine physicians (n = 
41); thus, it has underpowered results.  Nevertheless, despite the small sample size of the 
family medicine physicians, some significance was still found, showing that there may 
have been more significant results found with a larger sample size.  The sample size of 
family medicine physicians and IBS patients was also distributed unevenly (41 family 
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medicine physicians vs. 175 IBS patients), which is a major limitation when comparing 
these two groups.  
Culture.  It will be difficult to generalize the results to family medicine 
physicians and IBS patients outside of the United States.  Further, various cultural aspects 
were not included in the current study, though an individual’s culture can influence how 
he or she treats or views IBS (C. D. Gerson & M. Gerson, 2010; Zuckerman et al., 1996).  
The fact that there was a lack of multicultural representation due to the majority of the 
family medicine physician participants identifying as Christian and Caucasian, it is a 
limitation of the study because of the importance of cultural views about IBS.  Further, In 
the United States, more females than males are diagnosed with IBS (Chang et al., 2006; 
Payne, 2004), which was also seen with the 175 IBS patients who participated in this 
study (patient participants included 139 females, 33 males, 1 gender fluid person, and 1 
non-binary person).  As such, this study represents the attitudes and knowledge about IBS 
among mainly female IBS patients.  In contrast, the gender of the family medicine 
physician sample was more evenly distributed (23 females and 18 males).   
Measures.  The length of the measures may have hindered the study.  Family 
medicine physicians, specifically, have busy schedules and, therefore, likely did not have 
much time to fill out the measures.  This may explain the difficulty of obtaining a larger 
sample size of family medicine physician participants to respond to the survey.   
Another limitation of this study was its reliance on self-report from participants, 
particularly in regard to stating they have IBS, as no confirmatory evidence that they 
actually have IBS diagnoses and/or were diagnosed by family medicine physicians, 
internal medicine physicians, or gastroenterologists, was required.  Therefore, it is not 
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definite that the IBS patients all have IBS according to the diagnostic guidelines.  Also, 
there may have been confusion between IBS and IBD due to similarities between the 
symptoms (Dickman et al., 2011).  Overall, because of the use of self-report measures, 
there was potential for bias within the responses for both physicians and IBS patients.         
Another limitation is the fact that a new measure was created for the study: the 
14-item knowledge questionnaire.  This measure has not been tested with a larger sample 
and has not been validated in a randomized clinical trial.  Therefore, it cannot be assumed 
that this measures knowledge comprehensively due to not being psychometrically tested.  
Further, the lower scores on this measure may be explained by respondents missing key 
words in some of the items, such as “never” and “always.”  This may have confused 
some of the respondents when completing this measure.    
Finally, with regards to the attitudes measure, the IPQ-R, the seven subscales 
studied within this measure are clustered together by question, causing the subscales to 
not be randomized within the measure.  This means that each item in the measure was 
grouped with the other items that correlate with the same subscale, increasing face 
validity within the measure.  
Strengths  
Participants.  A strength of this study is the inclusion of medical residents, as 
56.1% of the family medicine participants identified as such.  There is a lack of research 
about family medicine physicians and treating IBS, even though family medicine 
physicians are the type of medical professionals who often have first contact with IBS 
patients (Hungin et al., 2014).  Moreover, medical residents’ overall knowledge base 
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about IBS is unclear.  Therefore, including family medicine physicians and residents is a 
major benefit to the literature about IBS.   
Rome IV criteria.  This study was conducted after the most recent establishment 
of the Rome IV criteria in 2016, a diagnostic tool that includes a list of symptoms one 
should meet to be diagnosed with IBS (Drossman, 2016).  This most recent diagnostic 
criteria for IBS was included in the knowledge questionnaire to examine whether the 
family medicine physicians in the sample were aware of the newest IBS diagnostic 
criteria.  It was found that the sample of family medicine physicians are not as 
knowledgeable as expected with regards to the newest Rome IV diagnostic criteria, 
scoring a 69.8% on the knowledge questionnaire that inquired about the Rome IV 
criteria. 
Future Directions  
The current study did not survey IBS patients and physicians outside of the 
United States, and culture affects views about IBS and treatment choices (C. D. Gerson & 
M. Gerson, 2010).  Therefore, it would be interesting to conduct a similar study with 
family medicine physicians and IBS patients in other countries, to study whether there are 
differences in findings depending on culture.  Additionally, more females than males are 
diagnosed with IBS in the United States, and many females struggle with being open 
about their IBS symptoms because of stereotypical gender roles such as feelings of shame 
and embarrassment about IBS symptoms (Chang et al., 2006).  Therefore, a study 
comparing attitudes among men and women diagnosed with IBS in the United States 
would be beneficial.   
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It would also be beneficial to do a similar study with other FGIDs that also 
present in family medicine settings.  There is research conducted with gastroenterologists 
and internal medicine physicians with regards to IBS; however, it would be useful to do a 
study with uncommon FGIDs, such as esophageal disorders, gastroduodenal disorders, 
centrally mediated disorders of gastrointestinal pain, gallbladder and SO disorders, and 
anorectal disorders (Drossman, 2016).  Further, comparing IBS knowledge and/or 
attitudes of first-year and third- or fourth- year medical school students would be another 
possible study, in order to gauge whether there are differences depending on level of 
training.  Due to the small sample size in this study of family medicine physicians, it 
would be helpful to conduct another study to collect a larger sample size of family 
medicine physicians.  Finally, it would be beneficial to determine whether here are 
differences in attitudes between DOs and MDs, and whether there are differences that 
depend on the age and years in practice for physicians.   
Conclusion 
Attitudes towards and the amount of knowledge about IBS can affect the patient-
physician relationship when physicians are treating IBS patients (Chang et al., 2006).  
Therefore, this study sought to specifically find whether there are differences in attitudes 
among family medicine physicians and IBS patients, considering family medicine 
physicians are often the first point of contact for IBS patients (Hungin et al., 2014).  If 
IBS patients hold negative attitudes toward IBS, a condition they are experiencing, this 
can have implications on their mental health and levels of stress related to the condition, 
which are two factors that easily affect the expression of one’s IBS symptoms (Hungin et 
al., 2005; van Tilburg et al., 2013).  This study found that the sample of family medicine 
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physicians and IBS patients demonstrated the same amount of knowledge, according to 
the 14-item knowledge measure.  Further, it was found that IBS patients feel more in 
control of IBS, perceive less negative emotions such as depression and anxiety, and 
perceive IBS to be more short-term compared to the family medicine physicians.  Also, 
IBS patients perceive the condition to be more of a mystery and puzzling compared to the 
family medicine physicians.  This study presents a need for more training and medical 
education regarding IBS within the medical field, specifically within the family medicine 
specialty.  If family medicine physicians are more educated about IBS and more educated 
about common experiences of IBS patients, then this will help these physicians educate 
their own patients about the condition and possibly improve patient-physician 
relationships.  Further, this study shows a need for integrative care, such as having 
behavioral health consultants and/or psychologists integrated within medical settings to 
help physicians and IBS patients treat IBS with evidenced-based treatment, while 
lessening the frustration associated with IBS.  In turn, this would also help improve 
patient-physician relationships.  The patient-physician relationship is valuable and can 
help make treatment more effective and increase adherence and, consequently, positive 
more outcomes for IBS patients.   
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Appendix A 
Patient Demographic Information 
Please complete the following demographic information.  Thank you for your 
participation.  
1. Which gender do you identify with? 
a. Female 
b. Male 
c. Other – Please Specify  
 
2. What is your age? _________ 
 
3. What is your ethnicity? 
a. African American 
b. Caucasian 
c. Spanish, Latino or Hispanic-American 
d. Native American or Alaska Native 
e. Asian or Pacific Islander  
f. Other – Please Specify  
 
4. What is your religious preference? 
a. Christian 
b. Islam 
c. Jewish  
d. Hindu  
e. Buddhist   
f. Agnostic 
g. Atheist  
h. None 
i. Other _________ 
 
5. What is your marital status? 
a. Married 
b. Divorced 
c. Widowed 
d. Not married, in relationship 
e. Not married, not in relationship 
f. Other _________ 
 
6. How many years have you been diagnosed with Irritable Bowel Syndrome (IBS)? 
a. _________ 
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7. What type of physician or medical professional diagnosed you with Irritable 
Bowel Syndrome (IBS)? 
a. Family medicine physician 
b. Gastroenterologist 
c. Other _________ 
 
8. What type of Irritable Bowel Syndrome (IBS), if known, were you diagnosed 
with? 
a. IBS with mainly constipation 
b. IBS with mainly diarrhea  
c. IBS with both diarrhea and constipation alternating 
d. IBS that does not fit into a category with a chief symptom like 
constipation or diarrhea 
e. Unknown 
 
9. Do you currently use medications or vitamins to treat your IBS? 
a. Yes 
b. No 
 
10. Do you currently use alternative treatments, such as exercise, yoga, relaxation 
training, or psychotherapy, to treat your IBS? 
a. Yes 
b. No 
 
11. Based on your answers to the above questions, please list any prescribed or 
unprescribed medications, vitamins, or alternative treatments that you currently 
use to treat your IBS. IF YOUR ANSWER IS “NONE” PLEASE WRITE IN 
“NONE” IN THE SPACE BELOW.  
 
 
 
 
 
 
 
 
 
 
 
IBS ATTITUDES AND KNOWLEDGE   76
Appendix B 
Physician Demographic Information 
Please complete the following demographic information.  Thank you for your 
participation.  
1. Which gender do you identify with? 
a. Female 
b. Male 
c. Other – Please Specify  
 
2. What is your age?  _________ 
 
3. What is your ethnicity? 
a. African American 
b. Caucasian 
c. Spanish, Latino or Hispanic-American 
d. Native American or Alaska Native 
e. Asian or Pacific Islander  
f. Other – Please Specify  
 
4. What is your religious preference? 
a. Christian 
b. Islam 
c. Jewish  
d. Hindu  
e. Buddhist   
f. Agnostic 
g. Atheist  
h. None 
i. Other _________ 
 
5. Which degree did you complete? 
a. Doctor of Osteopathic Medicine (DO) 
b. Doctor of Medicine (MD) 
 
6. Where did you complete your degree? 
a. United States 
b. Country outside of the United States 
 
7. What’s your current level of training at a family medicine setting? 
a. Resident 
b. Fellow 
c. Attending  
d. Other _________ 
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8. How many years have you been practicing? _________ 
 
9. What is your practice location? 
a. Urban 
b. Rural 
c. Suburban  
 
10.  Which treatment(s) do you typically recommend for an IBS patient?  Please 
check only two responses by checking the two most common recommended 
treatments. 
a. Medication based on symptoms (i.e., for constipation, diarrhea, bloating, 
pain, etc.) 
b. Psychotropic Medication 
c. Psychotherapy 
d. Physical Exercise 
e. Acupuncture 
f. Other _________ 
 
11. Have you attended any conferences, seminars, in-service trainings/presentations, 
or taken formal coursework specifically about Functional Gastrointestinal 
Disorders (FGIDs) and/or Irritable Bowel Syndrome (IBS) in the last five years? 
a. Yes 
b. No 
 
12. If yes to above question, please indicate below the number of trainings, 
conferences, seminars, in-service presentations you have attended in the past 
about FGIDs or IBS and subject of trainings (FGIDs or specifically IBS) – (for 
example, 2 trainings – IBS and IBD).  
 
13.  Do you have Irritable Bowel Syndrome (IBS)?  
a. Yes 
b. No 
 
14. Do you personally know anyone (family member, close friend, etc.) with Irritable 
Bowel Syndrome (IBS)? 
a. Yes 
b. No 
i. If yes, specify relationship below  
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Appendix C 
Knowledge Questionnaire 
  
Correct responses are in bold.  
 
1. There are 3 main types of IBS.  
a. True 
b. False 
 
2. IBS involves a brain and gut interaction. 
a. True  
b. False  
 
3. Men and women are equally bothered by their IBS symptoms.  
a. True  
b. False  
 
4. IBS is at least partly psychosomatic (mind affecting the body).  
a. True  
b. False  
 
5. To get the best treatment, it is important to know which subtype of IBS is 
occurring. 
a. True  
b. False  
 
6. Vomiting is a symptom of IBS. 
a. True  
b. False  
 
7. People with IBS have a greater risk for colon cancer. 
a. True  
b. False  
 
8. Physicians can use the Rome IV Criteria and conduct various tests to exclude 
other conditions. 
a. True  
b. False  
 
9. The cardinal and main identifying symptom of IBS is abdominal pain. 
a. True  
b. False  
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10. People with IBS will always have depression and/or anxiety.   
a. True 
b. False 
 
11.  Stress can make IBS symptoms worse.  
a. True 
b. False 
 
12. Abdominal pain, on average, should be experienced at least one day per week in 
the last 3 months to be diagnosed with IBS.  
a. True 
b. False 
 
13. Psychotherapy, such as Cognitive Behavioral Therapy (CBT) and mindfulness, 
are supported by research and proven to work for IBS.  
a. True 
b. False 
 
14. IBS does not lower a person’s quality of life and does not negatively affect a 
person’s general life satisfaction and overall happiness. 
a. True 
b. False 
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Appendix D 
Solicitation for Study 
Shana Brown-Lieberson, M.S. Psychology Doctoral student at the Philadelphia College 
of Osteopathic Medicine (PCOM), is currently seeking Irritable Bowel Syndrome (IBS) 
patients and family medicine physicians (residents, fellows, and attending physicians) to 
participate in a brief (15-20 minute) online survey for her Doctoral dissertation.  The 
research project is investigating the attitudes and knowledge about IBS.  Eligible patient 
participants must have been diagnosed with IBS by a family medicine physician, 
gastroenterologist, or internal medicine physician, be 18 years old or older, and be fluent 
in English.  Eligible physician participants must have graduated from an allopathic or 
osteopathic medical school in the United States and be working as a medical resident, 
fellow, or attending physician in a family medicine setting.  This study will be 
anonymous and confidential and participants may withdraw from the study at any time.  
Following the study, if interested, participants will be given the opportunity to enter their 
name for a $50 gift card from Amazon that will be raffled upon completion of the study.  
This raffle is separate from the survey and participants will not be able to be identified.  
This raffle will not be linked to survey data. This study has been reviewed and approved 
by the PCOM Institutional Review Board, protocol # H18030X.  Please follow the link to 
be directed to the online research study.  Questions can be directed to Dr. Barbara Golden 
at barbarago@pcom.edu.   
Thank you! 
 
